If you are:
Only When Necessary: NON-TERATOGENIC COMPLICATIONS (RESP, GI,CNS) WITH EXPOSURE DURING 3RD TRIMESTER
Absolute Contraindication: NOT RECOMMENDED BY MANUFACTURER;OTHER MEDICATIONS PREFERRED
An adult over 60:
management or monitoring precaution: Neuro/Psych-Higher risk of tardive dyskinesia. Anticholinergic effects cause sedation, worsen cognitive impairment and increase fall risk. Increased risk of death in senile dementia. Cardiovascular-Risk of orthostatic hypotension, dizziness, QT prolongation. Avoid use if significant cardiovascular condition. Monitor for hyperglycemia, lipid changes, weight gain. Gastrointestinal-May cause or worsen pre-existing constipation. Urogenital-Avoid in patients with urinary retention.
Giving ziprasidone HCl to a child under 12:
Severe Precaution: Adverse reactions include weight gain, glucose and lipid abnormalities, QT prolongation. Safety and efficacy in pediatrics not established.
management or monitoring precaution: Risk of sedation, dystonia, extrapyramidal reactions, QT prolongation, hyperprolactinemia, lipid, glucose abnormalities. Monitor weight. No safety and efficacy per manufacturer.